cbc.ca
Merck, Moderna say melanoma vaccine meets goals in large trial | CBC News
Merck and Moderna report that a personalized mRNA vaccine helped prevent skin cancer from returning in high-risk patients. Observers greeted the news with enthusiasm but noted that full data from the ...